Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Electrophysiological effects of irbesartan in patients with paroxysmal atrial fibrillation (AF)

Trial Profile

Electrophysiological effects of irbesartan in patients with paroxysmal atrial fibrillation (AF)

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Aug 2012

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Paroxysmal atrial fibrillation
  • Focus Therapeutic Use
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 01 Nov 2007 Status changed from in progress to completed.
    • 25 Jul 2007 Status changed from recruiting to in progress
    • 03 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top